Align thymidine phosphorylase (EC 2.4.2.4) (characterized)
to candidate 7023822 Shewana3_1042 thymidine phosphorylase (RefSeq)
Query= BRENDA::P07650 (440 letters) >FitnessBrowser__ANA3:7023822 Length = 443 Score = 603 bits (1554), Expect = e-177 Identities = 297/438 (67%), Positives = 354/438 (80%) Query: 1 MFLAQEIIRKKRDGHALSDEEIRFFINGIRDNTISEGQIAALAMTIFFHDMTMPERVSLT 60 MFLAQEIIRKKR+G ALS EEI+FF+ GI N +SEGQIAAL M ++F+DM M ER++LT Sbjct: 1 MFLAQEIIRKKRNGLALSTEEIQFFVKGITTNAVSEGQIAALGMAVYFNDMNMDERIALT 60 Query: 61 MAMRDSGTVLDWKSLHLNGPIVDKHSTGGVGDVTSLMLGPMVAACGGYIPMISGRGLGHT 120 AMRDSGTVL+W+SL LNGP++DKHSTGGVGDV SLMLGPM AACGGY+PMISGRGLGHT Sbjct: 61 TAMRDSGTVLNWQSLGLNGPVIDKHSTGGVGDVISLMLGPMAAACGGYVPMISGRGLGHT 120 Query: 121 GGTLDKLESIPGFDIFPDDNRFREIIKDVGVAIIGQTSSLAPADKRFYATRDITATVDSI 180 GGTLDK ++IPG+ P FR+++KDVGVAIIGQT L PADKRFY+ RD TATV+SI Sbjct: 121 GGTLDKFDAIPGYQTEPSSELFRKVVKDVGVAIIGQTGDLVPADKRFYSIRDNTATVESI 180 Query: 181 PLITASILAKKLAEGLDALVMDVKVGSGAFMPTYELSEALAEAIVGVANGAGVRTTALLT 240 LITASIL+KKLA LDAL MDVKVGSGAFMPTYE SE LA +I VANGAG +TTALLT Sbjct: 181 SLITASILSKKLACSLDALAMDVKVGSGAFMPTYEASEELARSIAAVANGAGTKTTALLT 240 Query: 241 DMNQVLASSAGNAVEVREAVQFLTGEYRNPRLFDVTMALCVEMLISGKLAKDDAEARAKL 300 DMNQVLAS AGNAVEV+EA+ FLTG YRNPRL+ VTM LC EML+ G LA D+A+ARAKL Sbjct: 241 DMNQVLASCAGNAVEVKEAIDFLTGAYRNPRLYAVTMGLCAEMLLLGGLASDEADARAKL 300 Query: 301 QAVLDNGKAAEVFGRMVAAQKGPTDFVENYAKYLPTAMLTKAVYADTEGFVSEMDTRALG 360 VLDNG+AAE+FG+MV+ GP DFVENY+KYLP + + + V+ADT+G+ MDTR LG Sbjct: 301 NRVLDNGRAAEIFGKMVSGLGGPVDFVENYSKYLPQSQIIRPVFADTQGYAYSMDTRELG 360 Query: 361 MAVVAMGGGRRQASDTIDYSVGFTDMARLGDQVDGQRPLAVIHAKDENNWQEAAKAVKAA 420 +AVV +GGGRR+ D +DYSVG T + LGD++D P+AVIHA+ E + +A +AVK A Sbjct: 361 LAVVTLGGGRRKPGDALDYSVGLTQVCALGDKIDASTPIAVIHAQSEEAFAQAEEAVKKA 420 Query: 421 IKLADKAPESTPTVYRRI 438 I + + APE TP +Y I Sbjct: 421 IHIDEVAPEKTPEIYAYI 438 Lambda K H 0.318 0.134 0.377 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 569 Number of extensions: 9 Number of successful extensions: 1 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 440 Length of database: 443 Length adjustment: 32 Effective length of query: 408 Effective length of database: 411 Effective search space: 167688 Effective search space used: 167688 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
Align candidate 7023822 Shewana3_1042 (thymidine phosphorylase (RefSeq))
to HMM TIGR02643 (deoA: thymidine phosphorylase (EC 2.4.2.4))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.carbon/TIGR02643.hmm # target sequence database: /tmp/gapView.8789.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR02643 [M=437] Accession: TIGR02643 Description: T_phosphoryl: thymidine phosphorylase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 2.5e-222 724.4 4.5 2.9e-222 724.2 4.5 1.0 1 lcl|FitnessBrowser__ANA3:7023822 Shewana3_1042 thymidine phosphor Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__ANA3:7023822 Shewana3_1042 thymidine phosphorylase (RefSeq) # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 724.2 4.5 2.9e-222 2.9e-222 1 437 [] 2 438 .. 2 438 .. 1.00 Alignments for each domain: == domain 1 score: 724.2 bits; conditional E-value: 2.9e-222 TIGR02643 1 llpqeiirkkrdglslsdeeiaafvegvtddsvsegqiaalamavyfngleldekvaltlamrdsGdvldwkdldln 77 +l+qeiirkkr+gl+ls+eei+ fv+g+t ++vsegqiaal mavyfn++++de++alt amrdsG+vl+w++l ln lcl|FitnessBrowser__ANA3:7023822 2 FLAQEIIRKKRNGLALSTEEIQFFVKGITTNAVSEGQIAALGMAVYFNDMNMDERIALTTAMRDSGTVLNWQSLGLN 78 79*************************************************************************** PP TIGR02643 78 gPvvdkhstGGvGdvvslmlaPivaacGgyvPmisGrGlGhtGGtldkleaiPGydvaPdeelfrkvvkdvGvaiiG 154 gPv+dkhstGGvGdv+slml+P+ aacGgyvPmisGrGlGhtGGtldk++aiPGy++ P++elfrkvvkdvGvaiiG lcl|FitnessBrowser__ANA3:7023822 79 GPVIDKHSTGGVGDVISLMLGPMAAACGGYVPMISGRGLGHTGGTLDKFDAIPGYQTEPSSELFRKVVKDVGVAIIG 155 ***************************************************************************** PP TIGR02643 155 qtadlaPadkrlyairdvtatvesiplitasilskklaaGldalvldvkvGnGafmesleeseelarslvevangaG 231 qt+dl Padkr+y+ird tatvesi+litasilskkla ldal++dvkvG+Gafm+++e seelars+ vangaG lcl|FitnessBrowser__ANA3:7023822 156 QTGDLVPADKRFYSIRDNTATVESISLITASILSKKLACSLDALAMDVKVGSGAFMPTYEASEELARSIAAVANGAG 232 ***************************************************************************** PP TIGR02643 232 vrttalitdmnqalasaaGnavevreavdfltGekrdkrleevtlalaaellvsgklaadeaeaeakleavlesGra 308 +ttal+tdmnq+las+aGnavev+ea+dfltG++r++rl +vt+ l+ae+l+ g+la+dea+a+akl++vl++Gra lcl|FitnessBrowser__ANA3:7023822 233 TKTTALLTDMNQVLASCAGNAVEVKEAIDFLTGAYRNPRLYAVTMGLCAEMLLLGGLASDEADARAKLNRVLDNGRA 309 ***************************************************************************** PP TIGR02643 309 aerfarmvaalgGPadfvekpekylakaaiakavkaaregylseidtrelGlavvalGGGrrkaddkldlsvGltdl 385 ae+f++mv+ lgGP dfve+++kyl++++i+++v a+++gy ++dtrelGlavv+lGGGrrk+ d ld+svGlt++ lcl|FitnessBrowser__ANA3:7023822 310 AEIFGKMVSGLGGPVDFVENYSKYLPQSQIIRPVFADTQGYAYSMDTRELGLAVVTLGGGRRKPGDALDYSVGLTQV 386 ***************************************************************************** PP TIGR02643 386 lelGekvekeeplavvhaadeedaeeaakavkkalkiadeaPeeakvvleri 437 lG+k+++ +p+av+ha++ee +++a +avkka++i++ aPe+++ +++ i lcl|FitnessBrowser__ANA3:7023822 387 CALGDKIDASTPIAVIHAQSEEAFAQAEEAVKKAIHIDEVAPEKTPEIYAYI 438 **********************************************999865 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (437 nodes) Target sequences: 1 (443 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.02 # Mc/sec: 6.83 // [ok]
This GapMind analysis is from Sep 17 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory